Welcome to LookChem.com Sign In|Join Free
  • or
C30H39N3O4Si is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

908567-38-4

Post Buying Request

908567-38-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

908567-38-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 908567-38-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,0,8,5,6 and 7 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 908567-38:
(8*9)+(7*0)+(6*8)+(5*5)+(4*6)+(3*7)+(2*3)+(1*8)=204
204 % 10 = 4
So 908567-38-4 is a valid CAS Registry Number.

908567-38-4Downstream Products

908567-38-4Relevant academic research and scientific papers

Treatment of Sepsis Pathogenesis with High Mobility Group Box Protein 1-Regulating Anti-inflammatory Agents

Cho, Wansang,Koo, Ja Young,Park, Yeonju,Oh, Keunhee,Lee, Sanghee,Song, Jin-Sook,Bae, Myung Ae,Lim, Donghyun,Lee, Dong-Sup,Park, Seung Bum

, p. 170 - 179 (2017/04/26)

Sepsis is one of the major causes of death worldwide when associated with multiple organ failure. However, there is a critical lack of adequate sepsis therapies because of its diverse patterns of pathogenesis. The pro-inflammatory cytokine cascade mediate

Discovery of novel benzopyranyl tetracycles that act as inhibitors of osteoclastogenesis induced by receptor activator of NF-κB ligand

Zhu, Mingyan,Kim, Myung Hee,Lee, Sanghee,Bae, Su Jung,Kim, Seong Hwan,Park, Seung Bum

supporting information; experimental part, p. 8760 - 8764 (2011/02/23)

A novel benzopyran-fused molecular framework 7ai was discovered as a specific inhibitor of RANKL-induced osteoclastogenesis using a cell-based TRAP activity assay from drug-like small-molecule libraries constructed by diversity-oriented synthesis. Its inhibitory activity was confirmed by in vitro evaluations including specific inhibition of RANKL-induced ERK phosphorylation and NF-κB transcriptional activation. 7ai can serve as a specific small-molecule modulator for mechanistic studies of RANKL-induced osteoclast differentiation as well as a potential lead for the development of antiresorptive drugs.

COMPOUNDS WITH EMBEDDED BENZOPYRAN MOTIF FOR CORE STRUCTURES AND PREPARATION METHOD THEREOF

-

Page/Page column 31, (2010/01/31)

The present invention relates to a compound having benzopyran core, a preparation method of the derivatives by liquid phase synthesis and solid phase synthesis through diversity-oriented synthesis, and an anticancer agent comprising the compound that exhi

COMPOUNDS WITH EMBEDDED BENZOPYRAN MOTIF FOR CORE STRUCTURES AND PREPARATION METHOD THEREOF

-

Page/Page column 53, (2008/12/06)

The present invention relates to a compound having benzopyran core, a preparation method of the derivatives by liquid phase synthesis and solid phase synthesis through diversity-oriented synthesis, and an anticancer agent comprising the compound that exhi

Concise and diversity-oriented synthesis of novel scaffolds embedded with privileged benzopyran motif

Ko, Sung Kon,Jang, Hwan Jong,Kim, Eunha,Park, Seung Bum

, p. 2962 - 2964 (2008/09/19)

A branching DOS strategy for an unbiased natural product-like library with embedded privileged benzopyran motif was established to provide complexity and diversity of resulting heterocycles with desired drug-likeness. The importance of skeletal diversity

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 908567-38-4